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During incomplete combustion of organic matter, nitro-polycyclic aromatic hydrocarbons (nitro-PAHs), are formed in a reaction that is catalyzed by a
low pH. 2-Nitrofluorene (NF), a marker for nitro-PAHs, is metabolized in vivo by two different routes. After inhalation, potent mutagenic metabolites,
hydroxylated nitrofluorenes (OH-NFs), are formed. The metabolites are distributed by systemic circulation. After oral administration, NF is reduced
to the corresponding amine, a reaction mediated by the intestinal microflora. This metabolite is acetylated to 2-acetylaminofluorene (AAF), a potent
carcinogen. Further ring-hydroxylation of AAF leads to detoxification and excretion. Induction of cytochrome P450s affects the metabolism, and
more OH-NFs are formed. As a consequence, more mutagenic metabolites are found in the circulation. OH-NFs are excreted in the bile as, in terms
of mutagenicity, totally harmless glucuronide conjugates. When these conjugates are excreted via the bile, intestinal )-glucuronidase can liberate
direct-acting mutagens in the intestine. Thus, inhalation of NF can lead to formation of potent mutagens in the intestine. NF is a direct-acting muta-
gen in bacterial assays and an initiator and promoter of the carcinogenic process, and gives rise to DNA adduct formation in laboratory animals. -
Environ Health Perspect 102(Suppl 4):139-146 (1994).
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Introduction
Incomplete combustion is a major problem
in terms of pollution. Examples include
emissions from energy production, vehicles,
smoking, and industrial processes. The bio-
logical effects induced by compounds
formed by incomplete combustion can be
divided into effects on human health and the
ecosystem. Both effects can be acute or long-
term. The different biological responses can
be related to each other because the same
substance in the emissions can give rise to
several reactions in the organism and the
ecosystem. One example ofthis is the nitrat-
ed polycyclic aromatic hydrocarbons (nitro-
PAHs). For the formation of nitro-PAHs,
incompletely combusted organic material
(PAH) and oxidized nitrogen (NOX) are
necessary. A low pH (SO2, NOx) catalyzes
the reaction. Because the formation ofnitro-
PAHs is catalyzed by a low pH, NOX, cat-
alyzes its own reaction with PAHs to form
nitro-PAHs. NOx is one important com-
bustion product responsible for acidification
of the environment, acute health effects (1)
as well as formation of nitro-PAHs (2).
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These compounds are strong genotoxic
agents in mammalian systems (3-7).
Nitro-PAHs are found in emissions from
diesel (8) as well as petrol (9) vehicles, the
exhaust from kerosene heaters (10), urban
air (11-14), river sediments (15), and cer-
tain food products (16,17), (Tables 1-3).
Nitro-PAHs can be formed during the
process ofcombustion or as a result ofpho-
tochemical reactions of PAHs (18) or
amino-PAHs (19) (Table 4). Nitro-PAH
formation reportedly has occurred in the
water phase with nitrite as a donor of the
nitro-group (20).
Nitro-PAHs are a group of at least 200
different substances. Many of them are
mutagens (21-24), and the most potent
mutagenic substances known of today,
Table 1. 2-Nitrofluorene in diesel exhaust.
Level Driving cycle Comment Reference
0.13 to 0.94 pg/km Bus (49)
0.11 to 1.5 pg/km Bus terminal (49)
4.1 pg/g LDD (48)
15± 1 pg/g SRM 1650 a (48)
0.63 pgg/g 100% load, moderated speed, HDD (48)
8.8 pg/g 75% load, high speed, HDD (48)
5.52 pgg/g In muffler (9)
+ New engine (29)
+ Dilution tunnel (29)
+ One cylinder engine, 75% load (106)
+ FTP LDD, Oldsmobile 5.7 liter, V8 engine (106)
+ Diesel exhaust (105)
+ Diesel exhaust (32)
+ Diesel exhaust (107)
+ Diesel exhaust (30)
+ LDD (108)
+ Diesel exhaust (28)
84 ppm b HDD, idle (51)
62 ppm b HDD, high speed, zero load (51)
1.9 ppm b HDD, high speed, full load (51)
+ Diesel particles (19)
0.11 ppm LDD (109)
90 pg/mile FTP LDD gas phase (summary 1980-1985) (35)
97 pg/mile FTP LDD particle phase (summary 1980-1985) (35)
+ LDD (8)
Abbreviations: HDD, heavy-duty diesel; LDD, light-duty diesel; +, identified, not quantified; FTP, U.S. federal test
procedure. a SRM, The National Bureau of Standards reference diesel particulate. b Concentration in particles.
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Concentration Source Reference
0.16 pg/g soot In mufflerfrom gasoline vehicle (9)
568 ng/m3 Exhaustfrom kerosene heater (116)
19.8 ng/m3 Close to kerosene heater exhaust (116)
+ Fuel aromatics + nitrogen dioxide (29)
++ Airplane engine emissions (120)
Abbreviations: +, identified, not quantified; ++, identified, high concentrations.
Table 3. 2-Nitrofluorene in the environment.
Concentration City/country Comments Reference
24-71 pg/m3 Tokyo and Kawasaki, Japan Three samplesfrom urban environments (74)
50-700 pg/im3 Beijing, China 38 samples, higher levels in urban areas (74)
310-5220 pg/m3 Berlin, Germany 24 samples, higher levels during winter (116,118)
and in areas dominated by heating
+ Berlin, Germany (117)
+ Tokyo, Japan (119)
1.5 pg/kg Suimon River, Japan River sediments (15)
+, identified, not quantified.
Table 4. Formation of 2-nitrofluorene by photochemical reactions.
Reaction Reference
F+ nitrite + UV light = increased mutagenicitya (20)
F+ nitrogen dioxide =2NF (2)
2AF+sunlight =2NF (110)
2AF+fluorescent light =formation of mutagens a (111)
2AF+ UV =2NF (19,110,112-115)
Abbreviations: 2NF, 2-nitrofluorene; 2AF, 2-aminofluorene; F, fluorene; UV, ultraviolet light. a No identification of
reaction products.
Table 5. The International Agency for Research on Cancer's evaluation on the human cancer risk of vehicle emis-
sions and some nitro-PAHs (33).
2A
x
Classification
Diesel engine exhaust
Gasoline engine exhaust
3,7-Dinitrofluoranthene
3,9-Dinitrofluoranthene
1,3-Dinitropyrene
1,6-Dinitropyrene
1,8-Dinitropyrene
7-Nitrobenzla]anthracene
6-Nitrobenz[a]pyrene
6-Nitrochrysene
2-Nitrofluorene
1-Nitronaphthalene
2-Nitronaphthalene
3-Nitroperylene
1-Nitropyrene
2-Nitropyrene
4-Nitropyrene
2B
x
x
x
x
x
x
x
Abbreviations: 1, carcinogenic to humans; 2A, probably carcinogenic to humans; 2B, possibly carcinogenic to
humans; 3, is not classifiable as to its carcinogenicity to humans.
dinitropyrenes, are found in this group
(25). A number ofthe nitro-PAHs are also
carcinogenic to laboratory animals (26,27).
2-Nitrofluorene (NF) is one ofthe more
common nitro-PAHs and is found in the
environment (28-32) with 1-nitropyrene
(NP). Normally NP is the dominating
species (29), although that is not always the
case (30). NF may be a model substance
for nitro-PAHs in the gas and particle
phase, while NP is regarded to be a model
substance for nitro-PAHs in the particle
phase (35). NF is a mutagen (24) as well
as a carcinogen (27) in laboratory animals.
NF has been studied in detail in our lab-
oratory from an analytical point of view
(36) and with regard to metabolism
(37-39), lung effects (40,41), and geno-
toxic effects (42-45). The International
Agency for Research on Cancer (IARC) has
evaluated the data on NF and some other
nitro-PAHs in terms ofhuman cancer risk
(33). The evaluation on diesel exhaust
(probably the major source for NF and
other nitro-PAHs) and other nitro-PAHs
are shown in Table 5.
Metabolism of2-Nitrofluorene
Humans can be exposed to NF, and nitro-
PAHs mainly via two routes. The direct
exposure is via inhalation with NF present
in the gas phase or absorbed on the surface
ofparticles. Large particles will enter into
the gastrointestinal tract after deposition in
the upper part ofthe inhalational system or
as a consequence of ciliary transport up
from the lungs.
The indirect exposure will occurs when
deposition ofpartides occurs on vegetables or
other products of agricultural origin for
human consumption. With the addition of
what can be added during food processing,
this way ofcontamination results in an expo-
sure to the gastrointestinal tract. There exist
other, possibly minor routes, such as by conta-
minated water and by water-living organisms
used as food. However, in this case the gas-
trointestinal tract is the end point. Therefore,
it is important to study the effect ofNF fol-
lowing oral and intratracheal administration.
Liquid Chromatography and Mass
Spectrometry Analses ofMetabolites
Liquid chromatography and mass spectrom-
etry analysis (LC/MS) with a nebulizer and
a moving belt was used to characterize NF
and its metabolites (36). The properties
and fragmentation patterns of 18 different
fluorene derivatives were examined first.
Without prior derivation, all substances
yielded interpretable mass spectra. The
LC/MS system had the capacity to distin-
guish between seven different hydroxylated
isomers of hydroxylated acetylaminofluo-
rene (OH-AAF). In combination with the
UV-analyses in the high pressure liquid
chromatography (HPLC) system, an identi-
fication could be performed based on the
retention time from the total or single ion
current chromatograms, differences in mass
spectral intensities, and specific losses of
fragments. In addition, HPLC analysis
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coupled with the radioactivity detector on
line indicated peaks with metabolites origi-
nating from the radiolabeled NF. The UV-
detector gave a signal that was linear and
parallel with the signal from the ion source,
demonstrating that although the two detec-
tors measure different parameters, they do
so at a constant ratio. Thus, the described
system was considered to be well suited for
the studies on the metabolism ofNF.
Metabolism afterOral
Administration ofNiltrofluorene
Although NF (and nitro-PAH in general) is
a chemically stable molecule, it is metabo-
lized extensively in the organism. After oral
administration ofNF, the major part ofthe
dose is excreted within 48-hr (37,39).
After 4 hr, approximately 1.5% ofthe dose
has been metabolized (in several steps) in
the liver, distributed in the circulation, fil-
tered by the kidneys, and excreted in the
urine. The excretion of metabolites is
accompanied by excretion ofmutagenicity.
Typically, direct-acting mutagenicity (-S9)
dominated over mutagenicity in the pres-
ence ofS9, both in urine and feces (37,39).
The in vivo formation (37) ofthe potent
carcinogen 2-acetylaminofluorene (AAF)
(46) isindicated. Afteran oral dose ofNF to
conventional rats, NF is reduced to 2-amino-
fluorene (AF) bythe intestinal microfloraand
acetylated and further hydroxylated in the
liver, which results in OH-AAFs. These can
be excreted as such or in conjugated form.
This metabolic route is quantitatively most
important. AAF has been a model com-
pound for chemical carcinogenesis since
Wllson's discovery ofits carcinogenic poten-
tial in 1941 (47). AAF is not found in the
environment, and occupational exposure can
occur only when AAF is used in research.
Thus, it is ofconcern when an environmen-
tal pollutant (NF) commonly found in
diesel exhaust (9,48,49,51) is metabolized
to this potent carcinogen (AAF) in vivo.
Although the biological significance of
these metabolites is not known, other
nitro-PAHs have been shown to form acety-
lated metabolites (52,53).
After oral administration ofNF, an alter-
native metabolic route that results in the for-
mation ofOH-NFs in the conventional ani-
mal forms (37). While OH-AAFs are con-
sidered to be detoxification products (54),
they have a low mutagenic potency (55).
OH-NFs, on the other hand, are more
mutagenic (TA 98-S9) than NF alone (39).
In conventional rats (37) treated with 3-
naphtoflavone prior to administration of
NF, the metabolic pattern shifted towards
excretion ofa larger proportion ofOH-NFs
Figure 1. A summary ofthe metabolism of 2-nitrofluorene (NF) in laboratory animals. or, oral; it, intratracheal; iv,
intravascular (organ perfusions) administration of NF; )NF, induction with ,B-naphthoflavone; germ-free, germ-free
animals (otherwise conventional animals).
in comparison with uninduced rats, and the
mutagenicity of urine increased simultane-
ously. Presently the carcinogenic potential
of OH-NFs has not been investigated in
detail, but it can not be denied that they are
carcinogenic. Therefore, they may be
involved in the induction of forestomach
tumors seen after oral dosing of NF. In
contrast, no forestomach tumors are seen
following administration ofAF or AAF.
OH-NFs may also play a role in the forma-
tion of subcutaneous tumors after skin
application ofNF to rats (56,27).
The involvement ofthe intestinal microflo-
ra in the metabolism ofNF was studied using
germ-free and conventional rats (39). The
mutagenicity of urine from germ-free ani-
mals exceeded the conventional urine in
direct-acting mutagenicity by a factor of
approximately six. The same observation
was made in feces (39). The LC/MS
analyses of urine and feces from germ free
animals confirmed the presence of OH-
NFs and the absence of OH-AAFs. NF
was excreted, to a small extent, in the
urine on 1 day following administration,
indicating the absorption of unreduced
NF from the gastrointestinal tract. The
major metabolic route in germ-free ani-
mals was the formation of OH-NFs,
which also were responsible for the excret-
ed direct-acting mutagenicity. In the
urine from germ free animals a di-OH-NF
was detected as the major metabolite in
terms of radioactivity (34%), although it
was only ofminor importance in terms of
mutagenicity (2%).
The mutagenicity of NF was increased
significantly after monohydroxylation
(39). Further hydroxylation appeared to
decrease the mutagenicity to levels below
NF. The formation of OH-NFs, their
potency in genotoxic assays, and possible
carcinogenic character indicate the need for
carcinogenicitystudies on this class ofcom-
pounds. The metabolism ofNF is summa-
rized in Figure 1.
Oral administration ofNP to rats result-
ed in the formation of reduced, acetylated,
and hydroxylated metabolites, but ring-
hydroxylated NPs were reported to be
responsible for a higher, direct-acting muta-
genicity in urine ofrats treated with pheno-
barbital (57), indicating the importance of
enzyme induction in the metabolism of
nitro-PAHs to mutagenic compounds.
Other studies have shown that pretreat-
ment of rats with f-naphtoflavone
increased the amount ofring-OH-AAFs in
milk after intraperitoneal administration of
AAF (58). This fact raises the question
whether the OH-NFs can also be excreted
in milk following the mothers inhalation of
urban air and/or diesel exhaust, which
would expose infants to a genotoxic risk.
Hydroxylated metabolites of NP under-
go nitroreduction and subsequent DNA
binding much more readily than NP (59),
leading to the conclusion of Beland et al
(60) that tumorigenicity assays should be
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conducted not only with the parent com-
pound and their reduced derivatives but
also with their ring-hydroxylated metabo-
lites to assess human health risks from
nitro-PAHs.
Metabolism after Inhalation
ofNitrofluorene
In the isolated perfused rat lung there is a
rapid metabolism to direct acting mutagens
when NF is administered intratracheally
and intravascularly. The metabolites
formed are unconjugated ring OH-NFs.
Unmetabolized NF given intratracheally
can also pass through the lung into the cir-
culation together with metabolites (OH-
NFs). Thus, it is likely that inhalation
might result in whole-body exposure to cir-
culating mutagens and carcinogens (NF and
OH-NFs). In the study performed on the
isolated perfused liver (38), the purpose was
to examine the type of metabolism occur-
ring when NF was administered intravascu-
larly, as the liver can be exposed to after
inhalation. The liver metabolized NF to
OH-NFs but excreted them, in terms of
mutagenicity, in a harmless form as glu-
curonides. Treatment of the bile with f-
glucuronidase liberated the direct-acting
mutagens, the OH-Ns.
,3-glucuronidase is an intestinal enzyme,
and its activity is high in individuals on an
"Western diet" (high in fat and protein)
(70). Thus, the results indicate a chain of
events. Inhaled NF is metabolized by the
lung to OH-NFs or transported to the liver
as NF and then is ring-hydroxylated. The
liver conjugates the OH-NFs and excretes
them via the bile. In the intestine, the OH-
NFs may be liberated, exposing the intes-
tine to a genotoxic risk. In other words, air
pollutants such as nitro-PAHs could be
found in the colon or other organs.
The results presented (38) are in accor-
dance with lung metabolic data on NP.
Lung microsomes from rats, rabbits, and
hamsters metabolize NP to mutagenic
products that were ring-hydroxylated (71).
Interestingly, nasal mucosa also metabolizes
NP to OH-NPs, a metabolic route that rep-
resented more than 90% ofthe metabolites
(72). Isolated perfused lung metabolized
NP in the same way as the nasal mucosa.
The rate of metabolism of NP in the lung
increased (i.e., the probability increased for
production of genotoxic metabolites, fol-
lowing exposure to diesel exhaust) (72).
Comparison betweenAnimals
andMan
One can always argue about whether data on
animal metabolism is relevant to humans,
but in the case of nitro-PAHs, there are a
number of arguments to indicate that the
animal studies are relevant to the human sit-
uation. a) Reduction of nitro-PAHs to
amino-PAHs can be performed by anaerobic
fecal bacterial suspension from humans as
well as rats (61-63). b) Human liver S9
bioactivated AF and AAF to mutagens (64).
c) Human hepatoma cell lines can perform
nitroreduction as well as ring-hydroxylation
ofNP (65). d) Liver microsomal metabo-
lism ofAAF is similar in rats and humans
(66). e) Human lymphocytes metabolize
AAF to ring- and N-hydroxy derivatives of
AAF (67). f) AAF metabolism is similar in
cultures ofepithelial cells from human and
rat bladder (68). g) It has been shown that
the carcinogen AAF given orally to humans
results in the same urinary metabolites as in
the rat (69).
Risk Identification of
2-Nitrofluorene
AcuteToxicity
The acute toxicity ofNF is low, indicated by
the low 24-hr LD50, which has been shown
to be 1.6 g/kg body weight (bw) in male
Swiss-Webster rats (80). The major risk
with exposure to NF is genotoxiceffects.
GenotoxicEffects
NF commonly is used as a positive control in
bacterial mutagenicity assays. Typically NF
has a direct-acting mutagenic effect (does not
require a metabolic system) in a number of
the Salmonella typhimuriumstrains (95-101).
NF is not among the most potent bacterial
mutagens that can be found in the family of
nitro-PAHs (Table 6).
In a liver model for chemical carcinogene-
sis, NF has been shown to be a potent initia-
tor. The statistically significant dose
response curve was approximately 10 times
the background at the highest dose (44).
When NF was characterized as a promoter,
the basic concept for the liver model was
used, but the dietary AAF-promotion regi-
men was replaced bysix intragastric adminis-
trations ofNF. At the lower dose similar to
the doses used in the NF metabolic studies,
NF andAAF were both weak promoters. At
high doses, AAF was averypotent promoter,
while NF remained at a low but statistically
significant level ofpromotingactivity (44).
NF given to laboratory animals under
different conditions gave rise to DNA
adduct formation. The major DNA adduct
characterized in the liverwas C8-guanine-2-
aminofluorene, indicating the importance
ofthe intestinal microflora in the reduction
of the nitro function to an amine (73).
Table 6. Mutagenicity (plate incorporation) of nitro-
fluorene and related substances.
TA98-S9,
Nitro-PAH revertants/nmole Reference
1-Nitronaphthalene 0.05 (89)
2-Nitrochrysene 0.6 (103)
5-Nitroacenaphtene 2.5 (89)
1-Nitrocoronene 2.8 (103)
2-Nitrofluorene 18 (89)
1-Nitrofluoranthene 74 (103)
2-Nitrophenanthrene 128 (46)
2-Nitrophenanthrene 453 (89)
2-Nitropyrene 2225 (103)
3-Nitrofluoranthene 3735 (89)
1,3-Dinitropyrene 144,700 (89)
1,6-Dinitropyrene 183,600 (89)
1,8-Dinitropyrene 254,000 (89)
Table 7. Sites of tumors after administration of nitro-
fluorene to rats.
Route
Organ Oral a,b Skinb Oral c
Mammarygland + +
Earduct + d
Pituitary gland + d
Adrenal gland +
Lung + + d
Salivarygland +
Forestomach + +
Liver + +
Intestine + d
Subcutaneous + d
Kidney +
Number of animals 18a 10 80
9 b
a Data from Miller et al. (27). b Data from Morris et al.
(56). c Ongoing study 1991 to 1993 (75). d Possible
tumors.
The DNA adducts formed by NF and
derivatives were characterized by the 32p-
postlabeling method (thin-layer chromatog-
raphy analyses) as well as by HPLC analyses
of32P-labeled DNA adducts. The develop-
ment of a HPLC method to characterize
32P-labeled DNA adducts opens new per-
spectives in terms ofseparation and charac-
terization DNA adducts in general (73).
There are three studies on the carcino-
genicity ofNF. Two were performed in the
early 1950s by Morris et al. (56) and
Miller et al. (27) on small groups of ani-
mals with only one dose studied. The third
is an ongoingstudyby Moller et al. (75).
These incomplete studies indicate that
NF is a potent carcinogen and induces
tumors in many different organs and glands
(e.g., liver, forestomach, intestine, kidneys,
lung, mammary gland, subcutaneous, pitu-
itary gland, ear duct, adrenal gland, and
salivary gland (Table 7) (56,27,75). In the
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Table 8. A summary of nitrofluorene's biological
effects.
Assay Effect Reference
Sister chromatid exchange + (3,82,83)
Chromosomal aberrations + (104)
Initiator + (44)
Promoter + (44)
Carcinogenicity + (27,56,75)
Formation of DNA adducts + (84)
Micronuclei assays - (6,86,87,88)
Mutation assay, + (85)
mammalian cells
Bacterial mutagenicity + (89,90,91)
(Salmonella)
Bacterial mutagenicity + (92)
(Escherichia coli)
Mutagenicity, + (81)
nematode assay
Mutagenicity, + (3,85,93)
mouse lymphoma assay
Induction of unscheduled + (43)
DNA synthesis
Abbreviations: +, positive effect; -, no effect.
ongoing study with NF administration in
the food at ppm levels, there was a dramatic
tumor formation in the high dose group of
500 ppm after 10 months of feeding. In
approximately 4 weeks, all animals devel-
oped very large liver tumors and multiple
forestomach tumors. The tumors in the
liver were up to 55 mm in diameter. In
many cases there were three to five tumors
with diameters above 20 mm. These pre-
liminary tumor data are in accordance with
the formation of DNA adducts in the liver
(73,75). The genotoxic effects of NF are
summarized in Table 8. A more extensive
review of NF and its biological effects has
been published by Beije and Moller (34).
Additional Factors intheRisk
AssessmentofGenotoxicEffects
In addition to the initiation oftumors, addi-
tional risks of NF as a marker for nitro-
PAHs, should be taken into consideration in
the risk assessment process. These risk fac-
tors might involve promotion of tumor
development and cocarcinogenic effects.
NF has been shown to have tumor pro-
moting capacity (44). Nitro-PAHs and
PAHs always occur together. Recent data
indicate that NP and benzo[a]pyrene are
potent cocarcinogens (94). Humans on a
"Western diet" have higher levels of intesti-
nal ,3-glucuronidase (70), which could result
in an increased liberation of genotoxic NF-
metabolites in the colon (44). Induction of
cytochrome P450s (possibly by other envi-
ronmental contaminants) results in the for-
mation of potent, direct-acting mutagens
and possible carcinogens (37). Certain food
components can affect intestinal nitro-reduc-
tases dramatically. Because the nitroreduc-
tion is a metabolic step this could be ofgreat
importance (L. Moller, unpublished data).
The possible effects ofalcohol consumption
on the metabolism of nitro-PAHs is also a
risk factor. Liver microsomes from rats with
prior dosing of ethanol metabolize NP in a
different manner (77), and hepatic micro-
somes from ethanol-fed hamsters bioacti-
vated AF more effectively (78).
There also could be effects on reproduction
considering that metabolites of nitro-PAH
have been reported to cause malformations in
laboratory animals (76). Nitrocompounds
have also been reported to cause infertility
and reduced sperm counts in rats (50).
There is a risk that human fertility could be
affected since nitro-derivatives negatively
affect human sperm motility (L. Moller,
unpublished data).
If a risk assessment is performed on
nitro-PAHs, there are certain groups of
individuals that can be considered high risk
groups if the data from animal models are
relevant for humans. The high risk groups
could be defined by exposures and eating
habits. One group would include those
exposed to other genotoxic substances
(smokers, certain occupational environ-
ments and urban populations) that can ini-
tiate tumor formation. Nitro-PAHs then
could function as cocarcinogens, promoters,
or both. Another group would include
those with certain food habits, like people
on a "Western diet." Also in this group
would be people who eat food containing
inducers ofthe cytochrome P450 system or
food prepared over an open fire.
Consumption ofalcohol is another possi-
ble risk factor. Food or components in food
have an influence on risk mainly via effects
on different enzyme systems, but food pro-
cessing under certain conditions could be
the major source for nitro-PAHs. For
example, a popular Japanese chicken dish
can contain as much nitropyrene as 3.5
years ofbreathing on the streets ofTokyo if
all inhaled nitropyrene is retained in the
lung (74,17).
Conclusion
NF is a result of incomplete combustion
and consequently can be found where com-
bustion takes place. It has been found in
emissions from vehicles with diesel-driven
diesel engines as the dominating source.
Other sources of combustion are gasoline
vehicles and kerosene heaters. NF can also
be found in different environments like
river sediments and urban air. The sources
producing it in urban air can be energy
generation, especially the combustion of
coal, as well as vehicles. An additional
source of NF in the environment is the
photochemical formation.
NF and derivatives may represent a large
portion ofpresent nitro-PAHs in the envi-
ronment. In one sample ofairborne particles
from Japan, NF and two isomers of dini-
tro-NF represented 55% of the amount of
19 analyzed nitro-PAHs (79). Humans
are exposed to NF, nitro-PAHs, or both
wherever combustion iffound.
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